scholarly article | Q13442814 |
P2093 | author name string | Ullian ME | |
Morinelli TA | |||
Walsh LG | |||
P433 | issue | 2 | |
P304 | page(s) | 266-273 | |
P577 | publication date | 1996-08-01 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Potentiation of angiotensin II action by corticosteroids in vascular tissue | |
P478 | volume | 32 |
Q96687046 | ACE2, Much More Than Just a Receptor for SARS-COV-2 |
Q35770232 | Aldosterone and cardiovascular remodelling: focus on myocardial failure |
Q33181046 | Aldosterone and vascular damage |
Q46864710 | Aldosterone antagonists in the treatment of heart failure |
Q36109237 | Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes. |
Q30442009 | Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption |
Q28578361 | ERK is regulated by sodium-proton exchanger in rat aortic vascular smooth muscle cells |
Q38745381 | Glucocorticoid-induced fetal origins of adult hypertension: Association with epigenetic events |
Q46862408 | Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer |
Q35209084 | RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease |
Q34585130 | Rationale for the use of aldosterone antagonists in congestive heart failure |
Q34718009 | Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells |
Search more.